Sigma Pharmaceuticals offers a Boxxdocks tracking solution to enhance ESG strategy
Sigma Pharmaceuticals, a leading and leading dealer company in the United Kingdom, cooperates with the creator of logistics technology, Boxxdocks, to enhance efficiency and sustainability in warehouse and transportation operations.
The partnership will see that Sigma will become the first company in the pharmaceutical industry that benefits from the advanced tracking technology of Boxxdocks to improve the vision and management of assets.
Reading: ACA Register 400 members
Boxdocks technology provides and tracking data-based data-the first of its kind in the supply chain and logistics services. This solution is not only dealt with the decisive issue of inventory loss, but also paves the way for environmental costs and benefits.
Unlike traditional tracking systems that provide a limited vision, BOXXDOCKS provides data in actual time about the location of assets and movement, allowing B2B distributors to set the entire supply chains with unprecedented efficiency. This ability can significantly enhance operational efficiency and reduce costs by improving the use of assets and reducing loss.
In addition, technology provides improved security for the elements under transit, which reduces waste and support the circular economy, by facilitating the shift towards reusable assets, instead of cardboard and monochromatic plastic, which reduces environmental and financial effects.
Read: The Union expanded the goods in the United States through Boston’s opening trip
“This partnership with Boxxdocks will help accelerate our commitment to sustainability and NHS net scratch goals. By the ability to track our assets, we will be able to reduce the environmental footprint by greatly reducing individual use materials.
“Our mission is to help enhance the B2B distribution through our smart and sustainable solutions and save costs. We are happy to work with Sigma Pharmaceuticals, a company that considers the best guidance,” said Alessandro Atanzio, CEO of Boxxdocks.
He added: “Through this cooperation, we have improved our technology to meet the specific needs of the pharmaceutical sector. It is a bright example of how to convert our technology, reduce the cost and environmental impact, and help pushing the industry forward to achieve the goals of efficiency and sustainability.”
